DE69218813T2 - Ringsubstituierte 2-Amino-1,2,3,4-tetrahydronaphthaline - Google Patents
Ringsubstituierte 2-Amino-1,2,3,4-tetrahydronaphthalineInfo
- Publication number
- DE69218813T2 DE69218813T2 DE69218813T DE69218813T DE69218813T2 DE 69218813 T2 DE69218813 T2 DE 69218813T2 DE 69218813 T DE69218813 T DE 69218813T DE 69218813 T DE69218813 T DE 69218813T DE 69218813 T2 DE69218813 T2 DE 69218813T2
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- tetrahydronaphthalenes
- amino
- substituted
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65358391A | 1991-02-08 | 1991-02-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69218813D1 DE69218813D1 (de) | 1997-05-15 |
DE69218813T2 true DE69218813T2 (de) | 1997-08-14 |
Family
ID=24621480
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69218813T Expired - Fee Related DE69218813T2 (de) | 1991-02-08 | 1992-02-03 | Ringsubstituierte 2-Amino-1,2,3,4-tetrahydronaphthaline |
DE69231538T Expired - Fee Related DE69231538T2 (de) | 1991-02-08 | 1992-02-03 | Ringsubstituierte 2-Amino-1,2,3,4-tetrahydronaphtahline und 3-Aminochromane |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69231538T Expired - Fee Related DE69231538T2 (de) | 1991-02-08 | 1992-02-03 | Ringsubstituierte 2-Amino-1,2,3,4-tetrahydronaphtahline und 3-Aminochromane |
Country Status (26)
Country | Link |
---|---|
US (2) | US5426226A (de) |
EP (2) | EP0498590B1 (de) |
JP (1) | JP3283892B2 (de) |
KR (1) | KR100219995B1 (de) |
CN (2) | CN1036392C (de) |
AT (2) | ATE197145T1 (de) |
AU (2) | AU653197B2 (de) |
BR (1) | BR9200426A (de) |
CA (1) | CA2060815C (de) |
CZ (1) | CZ288067B6 (de) |
DE (2) | DE69218813T2 (de) |
DK (2) | DK0712837T3 (de) |
ES (2) | ES2102456T3 (de) |
FI (1) | FI920526A (de) |
GR (2) | GR3023601T3 (de) |
HU (3) | HU221184B1 (de) |
IE (1) | IE920417A1 (de) |
IL (3) | IL114760A (de) |
MX (1) | MX9200505A (de) |
MY (1) | MY116454A (de) |
NO (1) | NO301825B1 (de) |
NZ (2) | NZ241495A (de) |
PT (1) | PT712837E (de) |
RU (2) | RU2057751C1 (de) |
YU (1) | YU48927B (de) |
ZA (1) | ZA92767B (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2048846A1 (en) * | 1990-08-15 | 1992-02-16 | Craig Steven Hoechstetter | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and aminothiochromanes |
ATE197145T1 (de) * | 1991-02-08 | 2000-11-15 | Lilly Co Eli | Ringsubstituierte 2-amino-1,2,3,4- tetrahydronaphtahline und 3-aminochromane |
US5434174A (en) * | 1992-07-17 | 1995-07-18 | Eli Lilly And Company | Isoxazole derivatives for the treatment of irritable bowel syndrome |
EP0697894A4 (de) * | 1993-03-31 | 1996-05-01 | Univ Pennsylvania | Dopamin d-3 und serotonin (5-ht 1a) rezeptor-liganden und bildgebunde mittel |
IL110857A0 (en) * | 1993-09-09 | 1994-11-28 | Lilly Co Eli | Cessation of tobacco use |
SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
US6355674B1 (en) | 1997-04-30 | 2002-03-12 | Eli Lilly And Company | Aminotetralins as 5-HT1D α Agonists |
EP1052982A4 (de) * | 1997-04-30 | 2004-10-06 | Lilly Co Eli | AMINOTETRALINE ALS 5HT1D-alpha AGONISTEN |
NZ501251A (en) | 1997-07-01 | 2001-09-28 | Pfizer | Sertraline salts and sustained-release dosage forms of sertraline |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
BR9913503A (pt) | 1998-09-09 | 2002-01-29 | Ishihara Sangyo Kaisha | Derivados de benzeno-fundidos úteis como herbicidas |
FR2792529B1 (fr) * | 1999-04-26 | 2001-09-28 | Sod Conseils Rech Applic | Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines |
US6792563B1 (en) * | 2000-04-28 | 2004-09-14 | Intel Corporation | Method and apparatus for bus activity tracking |
CA2472763A1 (en) * | 2002-02-13 | 2003-08-21 | Pharmagene Laboratories Limited | 5-ht2b receptor antagonists |
SE0301794D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use III |
SE0301795D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use I |
SE0301798D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use IV |
SE0301796D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use II |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ192641A (en) * | 1979-01-26 | 1984-10-19 | Hoffmann La Roche | Substituted acetophenones and pharmaceutical compositions |
SE8004002L (sv) * | 1980-05-29 | 1981-11-30 | Arvidsson Folke Lars Erik | Terapeutiskt anvendbara tetralinderivat |
US4801605A (en) * | 1986-08-29 | 1989-01-31 | Ciba-Geigy Corporation | 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans |
SE8605504D0 (sv) * | 1986-12-19 | 1986-12-19 | Astra Laekemedel Ab | Novel chroman derivatives |
DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
US5214156A (en) * | 1988-03-25 | 1993-05-25 | The Upjohn Company | Therapeutically useful tetralin derivatives |
CA1335591C (en) * | 1988-05-23 | 1995-05-16 | James Arthur Nixon | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes |
CA1335106C (en) * | 1989-02-27 | 1995-04-04 | John Mehnert Schaus | Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes |
FR2647365B1 (fr) * | 1989-05-24 | 1991-08-30 | Inst Francais Du Petrole | Catalyseur multifonctionnel pour le traitement des gaz d'echappement des moteurs a combustion interne, contenant de l'uranium, au moins un promoteur de l'uranium et au moins un metal precieux et sa preparation |
SE8901889D0 (sv) * | 1989-05-26 | 1989-05-26 | Astra Ab | Novel 8-substituted-2-aminotetralines |
ATE172712T1 (de) * | 1989-05-31 | 1998-11-15 | Upjohn Co | Zns-wirksame 8-heterocyclyl-2-aminotetralin derivate |
DE3919624A1 (de) * | 1989-06-15 | 1990-12-20 | Boehringer Ingelheim Kg | Neue 2,5-diaminotetraline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
CA2028341A1 (en) * | 1989-10-23 | 1991-04-24 | Junichi Sato | 5-substituted-2,4-diphenylpyrimidine derivatives, their production and use |
SE8904361D0 (sv) * | 1989-12-22 | 1989-12-22 | Astra Ab | New chroman and thiochroman derivatives |
US5420151A (en) * | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
CA2048846A1 (en) * | 1990-08-15 | 1992-02-16 | Craig Steven Hoechstetter | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and aminothiochromanes |
ATE197145T1 (de) * | 1991-02-08 | 2000-11-15 | Lilly Co Eli | Ringsubstituierte 2-amino-1,2,3,4- tetrahydronaphtahline und 3-aminochromane |
-
1992
- 1992-02-03 AT AT96200393T patent/ATE197145T1/de not_active IP Right Cessation
- 1992-02-03 DK DK96200393T patent/DK0712837T3/da active
- 1992-02-03 AT AT92300887T patent/ATE151419T1/de not_active IP Right Cessation
- 1992-02-03 DK DK92300887.4T patent/DK0498590T3/da active
- 1992-02-03 ES ES92300887T patent/ES2102456T3/es not_active Expired - Lifetime
- 1992-02-03 ES ES96200393T patent/ES2153071T3/es not_active Expired - Lifetime
- 1992-02-03 EP EP92300887A patent/EP0498590B1/de not_active Expired - Lifetime
- 1992-02-03 ZA ZA92767A patent/ZA92767B/xx unknown
- 1992-02-03 IL IL11476092A patent/IL114760A/xx not_active IP Right Cessation
- 1992-02-03 DE DE69218813T patent/DE69218813T2/de not_active Expired - Fee Related
- 1992-02-03 IL IL10085892A patent/IL100858A/en not_active IP Right Cessation
- 1992-02-03 DE DE69231538T patent/DE69231538T2/de not_active Expired - Fee Related
- 1992-02-03 EP EP96200393A patent/EP0712837B1/de not_active Expired - Lifetime
- 1992-02-03 NZ NZ241495A patent/NZ241495A/en not_active IP Right Cessation
- 1992-02-03 PT PT96200393T patent/PT712837E/pt unknown
- 1992-02-05 CZ CS1992332A patent/CZ288067B6/cs not_active IP Right Cessation
- 1992-02-06 KR KR1019920001720A patent/KR100219995B1/ko not_active IP Right Cessation
- 1992-02-06 JP JP02109892A patent/JP3283892B2/ja not_active Expired - Fee Related
- 1992-02-06 AU AU10775/92A patent/AU653197B2/en not_active Ceased
- 1992-02-06 MY MYPI92000186A patent/MY116454A/en unknown
- 1992-02-06 MX MX9200505A patent/MX9200505A/es not_active IP Right Cessation
- 1992-02-06 NO NO920489A patent/NO301825B1/no unknown
- 1992-02-07 CN CN92100794A patent/CN1036392C/zh not_active Expired - Fee Related
- 1992-02-07 HU HU9200396A patent/HU221184B1/hu not_active IP Right Cessation
- 1992-02-07 BR BR929200426A patent/BR9200426A/pt not_active Application Discontinuation
- 1992-02-07 YU YU12992A patent/YU48927B/sh unknown
- 1992-02-07 CA CA002060815A patent/CA2060815C/en not_active Expired - Fee Related
- 1992-02-07 IE IE041792A patent/IE920417A1/en not_active IP Right Cessation
- 1992-02-07 RU SU925011019A patent/RU2057751C1/ru not_active IP Right Cessation
- 1992-02-07 HU HU9500495A patent/HU225163B1/hu not_active IP Right Cessation
- 1992-02-07 FI FI920526A patent/FI920526A/fi not_active IP Right Cessation
-
1993
- 1993-10-21 US US08/140,903 patent/US5426226A/en not_active Expired - Fee Related
-
1994
- 1994-08-24 NZ NZ264302A patent/NZ264302A/en not_active IP Right Cessation
- 1994-12-20 RU RU94044322A patent/RU2105756C1/ru not_active IP Right Cessation
- 1994-12-22 AU AU81687/94A patent/AU664520B2/en not_active Ceased
-
1995
- 1995-06-22 HU HU95P/P00389P patent/HU211848A9/hu unknown
- 1995-07-27 IL IL11476095A patent/IL114760A0/xx unknown
- 1995-08-22 US US08/517,781 patent/US5571942A/en not_active Expired - Fee Related
-
1996
- 1996-02-06 CN CN96103586A patent/CN1052218C/zh not_active Expired - Fee Related
-
1997
- 1997-05-30 GR GR970401244T patent/GR3023601T3/el unknown
-
2001
- 2001-01-04 GR GR20010400008T patent/GR3035190T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69218813T2 (de) | Ringsubstituierte 2-Amino-1,2,3,4-tetrahydronaphthaline | |
ZA881377B (en) | Process for improving the photochemical stability of dyeings on polyester fibre materials | |
AU639053B2 (en) | Immunosuppressant and process for preparing the same | |
IT1250749B (it) | Composti eterociclici ad attivita' a ii antagonista | |
HU9202199D0 (en) | A new medical preparative containing benzomorphane | |
HUP9700103A2 (hu) | 1,3,4-Tiadiazol-származékok és eljárás előállításukra |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |